Home » Topics » Regulatory » Patents

Patents
RSS

New use claimed for olanzapine

Nov. 26, 1996

Melatonin receptor ligands described by ADIR

Nov. 26, 1996

New retinoid-like compounds from BMS

Nov. 26, 1996

New NMDA antagonists described by Zeneca

Nov. 26, 1996

Asta Medica reports new PDE IV and PDE V inhibitors

Nov. 26, 1996

Cyclic hexapeptide antifungal agents claimed by Lilly

Nov. 26, 1996

New antihypertensive agent from Calpis Food Industry

Nov. 26, 1996

Sandoz claims MAbs against Lewis group antigens for therapeutic use

Nov. 25, 1996

More antiobesity proteins reported by Lilly

Nov. 25, 1996

Maxi-K channel modulators from Bristol-Myers Squibb

Nov. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...